MENU
QLGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Qualigen Therapeutics (QLGN) Ownership - Who owns Qualigen Therapeutics?
Profile
Industry
N/A
Address
5857 Owens Avenue
Phone
+1 760 452-8111
Employees
4
Web
https://www.qlgntx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.12M
P/E Ratio
0.00
Total Cash
388.15K
Projected Growth
N/A
Total Debt
1.43M
Revenue
N/A
Risk (Beta)
0.05
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
QLGN
Capitalization
3.12M
P/E Ratio
0.00
Risk (Beta)
0.05
Dividend Yield
N/A
Total Cash
388K
Total Cash/Share
0.53
Total Debt
1.43M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.14M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
4.08K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
65.3K
Current Ratio
0.52
Current Revenue Per Employee
42816.61
Dividends Per Share - Security
N/A
EBITDA
-6.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
37.52
Revenue To Assets
-239.59
Shares Held By Institutions
67.4K
Shares Outstanding - Current
736K
Total Liabilities
4.45M
Total Volume MTD
N/A
Value
1
Gain YTD
-84.618
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company which focused on developing therapeutics for the treatment of cancer and infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5857 Owens Avenue
Phone
+1 760 452-8111
Employees
4
Web
https://www.qlgntx.com